Johnson & Johnson Raises 2026 Revenue Growth Forecast to 6.1%
MDT•Johnson & Johnson raised its 2026 revenue growth forecast to 6.1% on April 14 and outlined a path to double-digit growth by 2030, backed by its largest ever pipeline. Since the update, shares have returned -0.2% while implied volatility in options has climbed to the 85th percentile.
1. Guidance Raise and Growth Targets
Johnson & Johnson raised its full-year revenue growth forecast for 2026 to 6.1% on April 14 and projected double-digit growth by 2030, bolstered by what it calls its strongest portfolio pipeline in company history.
2. Stock Reaction to Outlook
Despite the bullish update, shares have returned -0.2% since the guidance announcement, as investors weigh management’s promises against execution risks including a recent $32 million asbestos verdict and questions over MedTech segment growth.
3. Options Market Signals
Implied volatility in Johnson & Johnson options has surged to the 85th percentile of its one-year range, signaling that traders are pricing in a significant move ahead of the next earnings report.
